A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System. [PDF]
Weppner WG +4 more
europepmc +1 more source
Evaluation of comparative efficacy of Umeclidinium/Vilanterol versus other bronchodilators in the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of RCTs. [PDF]
Zhu H, Lei J, Gao F, Guo Y, Zhao L.
europepmc +1 more source
Rationale and Design of an Exploratory, Randomized, Open-Label, Multicenter Clinical Trial to Investigate the Efficacy of Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist on Heart Failure Complicated by Chronic Obstructive Pulmonary Disease (COPD-HF Trial). [PDF]
Hayashi H +18 more
europepmc +1 more source
Dynamic chest radiographic evaluation of the effects of tiotropium/olodaterol combination therapy in chronic obstructive pulmonary disease: the EMBODY study protocol for an open-label, prospective, single-centre, non-controlled, comparative study. [PDF]
Ikari J +22 more
europepmc +1 more source
Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review. [PDF]
Lee HW.
europepmc +1 more source
Assessing the impact of implementing the clinical protocol and therapeutic guidelines in COPD in real-life. [PDF]
Sales DAL +5 more
europepmc +1 more source
Long-acting muscarinic antagonist and long-acting β<sub>2</sub>-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review. [PDF]
Buhl R +3 more
europepmc +1 more source
Mechanistic basis for the antifibrotic actions of cAMP-based therapies. [PDF]
Peters-Golden M, Fortier SM.
europepmc +1 more source
Anesthetic Management for an Elderly Patient With Severe Bronchiectasis. [PDF]
Takahashi T +8 more
europepmc +1 more source
Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO). [PDF]
Lai YT +14 more
europepmc +1 more source

